Amid the volatility in oil prices and dampened global economic growth due to the outbreak of COVID-19, the Kingdom of Saudi Arabia (KSA) healthcare market is expected to grow to $16.1 billion in value at 8.8% in 2020.
This research service provides deep perspectives and bold predictions for the KSA healthcare market in 2020. Pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT are some of the sectors covered. The analysis captures sectoral and regional trends and offers predictions for the upcoming year. The study provides guidance on where to find the greatest opportunities for expansion.
Key Issues Addressed
What are the top predictions for the KSA healthcare industry for 2020?
What are the market revenue and growth rates expected for the KSA healthcare market?
What are the key projections and growth opportunities for major healthcare segments?
What are the major macroeconomic and demographic factors that will affect the KSA healthcare industry?
What are the key technologies and growth opportunities to watch out for in 2020?
What are the key companies to watch during 2020?
KSA's pharmaceutical and MedTech markets are primarily import driven, therefore the impact of COVID-19 cannot be measured in terms of incidence of COVID-19 in KSA but in terms of the disruption in the global supply chain of the EU and China, which will impact the KSA healthcare industry.
Health and social development is the key sector in the KSA government, as it holds 16.4% of the country's budget expenditure, the third-largest share in 2020. There has been a relative decrease in the allocation of healthcare budget which can be attributed to the increase in private player participation and the focus on preventive care through various awareness programs. KSA free public healthcare system (Saudi citizens and public sector workers) is essentially funded by oil revenue which is under great strain. The rising cost of medical technologies, the changing demographic profile, the increasing prevalence of chronic diseases, and the increasing demand for quality healthcare are putting pressure on the KSA healthcare system to adopt cost-containment measures.
For KSA, 2020 will be a reality check on its National Transformation Program (NTP 2020), the biggest vision realization program of its ambitious Saudi Vision 2030. KSA's top priorities in the healthcare sector are to enhance the role of the private sector through privatization of government healthcare services, to increase public-private participation (PPP) healthcare delivery models, to scale up medical education and training of its local workforce and to boost the adoption of digital information systems, thereby creating a plethora of opportunities for investors, pharmaceutical and MedTech manufacturers, healthcare IT vendors, and support services.
The low level of domestic pharmaceutical drug production (about 20% to 30%), coupled with the ambition to diversify into non-oil sectors (e.g., bioeconomy) will continue to make the localization of pharmaceuticals manufacturing a lucrative opportunity for KSA in 2020. In addition, the disruption of the global supply chain due to COVID-19 outbreak can create a shortage of APIs, drugs, medical products, and equipment. To reduce its dependence on imported drugs, KSA can upscale its manufacturing capacity and strive to become an alternative supplier in 2 to 3 years. Government initiatives to increase local pharmaceutical manufacturing through public-private partnerships have led to the increasing collaboration between the domestic and global pharmaceutical formulation manufacturers, creating a win-win situation for both and making KSA a potential generic manufacturing hub of the MENA region.
Despite the presence of several general hospitals, there are supply gaps for several specialty areas, spurring governments to harness PPP models to build specialty clinics for gynecology, oncology, and cosmetology. Lifestyle disorders and the shift toward wellness and preventive care will boost the demand for remote health monitoring solutions that leverage Artificial Intelligence (AI) platforms. This will catapult investment toward non-hospital settings, such as long-term rehabilitation centers, and fitness and wellness centers.
The private sector has a larger role to play in filling the demand-supply gap in healthcare infrastructure and services. The increasing number of private hospitals will bridge the gap of quality and accessibility of healthcare services in public hospitals which is a major concern in healthcare delivery. The increase in investments in enterprise healthcare IT solutions and connected medical devices with AI capabilities that drive efficiencies will play a major role in the shift to a performance-based value system.
KSA will continue to hold the largest share in the MENA healthcare market. An increasingly affluent population will drive the demand for research-based branded generic drugs, connected medical devices, next-gen Imaging equipment, quality point-of-care diagnostic tests, and digital health solutions.
Key Topics Covered
1. Executive Summary
Top 5 Predictions for the 2020 KSA Healthcare Industry
Impact of COVID-19 Outbreak on KSA Healthcare Industry Predictions
The Impact of the COVID-19 Outbreak on the KSA Healthcare Industry
KSA Macro Trends
KSA Healthcare Industry Revenue, 2019-2020
Key Growth Opportunities by Sector
2. Key 2020 KSA Healthcare Market Predictions
Prediction #1: KSA will Become the Branded Generics Manufacturing Hub of MENA Region.
Prediction #2: Focus on Wellness and Preventive Care will Catapult Investment Toward Non-hospital Settings.
Prediction #3: KSA Healthcare Expenditure on Diabetes and Other Lifestyle Disorders will Increase.
Prediction #4: KSA Will Emerge as the Fastest Growing Digital Health Market in the GCC Region.
Prediction #5: The Demand for Specialty Clinics and Ambulatory Care Center will Drive Privatization.
3. Overview of the KSA Macroeconomic and Demographic Healthcare Environment
KSA Macroeconomic Healthcare Determinants
KSA Healthcare System Overview
KSA Hospital and Bed Density
Healthcare Financing in KSA
KSA Demographic Overview
4. Market Projections by Healthcare Segment
Pharmaceuticals and Biotechnology - Revenue Forecast
Pharmaceuticals and Biotechnology - Key Growth Opportunities
Pharmaceuticals and Biotechnology - Companies to Watch